Usefulness of the culturally adapted oxygen-cost diagram in the assessment of dyspnea in Puerto Rico.

@article{JessBerros2015UsefulnessOT,
  title={Usefulness of the culturally adapted oxygen-cost diagram in the assessment of dyspnea in Puerto Rico.},
  author={Yohana De Jes{\'u}s-Berr{\'i}os and Ruth A Santos-Rodr{\'i}guez and Donald Dexter and Mariely Nieves-Plaza and Cruz Mar{\'i}a Nazario},
  journal={Puerto Rico health sciences journal},
  year={2015},
  volume={34 1},
  pages={14-9}
}
OBJECTIVE Breathlessness is a common and disabling symptom of pulmonary disease. Measuring its severity is recommended as such measurements can be helpful in both clinical and research settings. The oxygen-cost diagram (OCD) and the Medical Research Council (MRC) dyspnea scale were developed in English to measure severity of dyspnea. These scales were previously translated to Spanish and adapted for use in a Hispanic population. The objective of this study is to assess the psychometric… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Breathlessness is a common and disabling symptom of pulmonary disease .
Subjects having pulmonary disease rated their perceptions of dyspnea using the scales , performed a spirometry test , and did a 6-min walk .
Breathlessness is a common and disabling symptom of pulmonary disease .
Subjects having pulmonary disease rated their perceptions of dyspnea using the scales , performed a spirometry test , and did a 6-min walk .
Subjects having pulmonary disease rated their perceptions of dyspnea using the scales , performed a spirometry test , and did a 6-min walk .
Breathlessness is a common and disabling symptom of pulmonary disease .
Subjects having pulmonary disease rated their perceptions of dyspnea using the scales , performed a spirometry test , and did a 6-min walk .
Breathlessness is a common and disabling symptom of pulmonary disease .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
Sixty - six patients having stable asthma ( n = 36 ) , chronic obstructive pulmonary disease ( n = 19 ) , or interstitial lung disease ( n = 11 ) participated in the study .
All Topics